Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection

被引:96
作者
Lichterfeld, Mathias
Yu, Xu G.
Mui, Stanley K.
Williams, Katie L.
Trocha, Alicja
Brockman, Mark A.
Allgaier, Rachel L.
Waring, Michael T.
Koibuchi, Tomohiko
Johnston, Mary N.
Cohen, Daniel
Allen, Todd M.
Rosenberg, Eric S.
Walker, Bruce D.
Altfeld, Marcus
机构
[1] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02129 USA
[2] Harvard Univ, Sch Med, Div Aids, Boston, MA USA
[3] Howard Hughes Med Inst, Chevy Chase, MD USA
[4] Fenway Community Hlth, Boston, MA USA
关键词
D O I
10.1128/JVI.01388-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type I (HIV-1)-specific CD8(+) T cells in early infection are associated with the dramatic decline of peak viremia, whereas their antiviral activity in chronic infection is less apparent. The functional properties accounting for the antiviral activity of HIV-1-specific CD8(+) T cells during early infection are unclear. Using cytokine secretion and tetramer decay assays, we demonstrated in intraindividual comparisons that the functional avidity of HIV-1-specific CD8(+) T cells was consistently higher in early infection than in chronic infection in the presence of high-level viral replication. This change of HIV-1-specific CD8(+) T-cell avidity between early and chronic infections was linked to a substantial switch in the clonotypic composition of epitope-specific CD8(+) T cells, resulting from the preferential loss of high-avidity CD8(+) T-cell clones. In contrast, the maintenance of the initially recruited clonotypic pattern of HIV-1-specific CD8(+) T cells was associated with low-level set point HIV-1 viremia. These data suggest that high-avidity HIV-1-specific CD8(+) T-cell clones are recruited during early infection but are subsequently lost in the presence of persistent high-level viral replication.
引用
收藏
页码:4199 / 4214
页数:16
相关论文
共 60 条
[1]   Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load [J].
Addo, MM ;
Yu, XG ;
Rathod, A ;
Cohen, D ;
Eldridge, RL ;
Strick, D ;
Johnston, MN ;
Corcoran, C ;
Wurcel, AG ;
Fitzpatrick, CA ;
Feeney, ME ;
Rodriguez, WR ;
Basgoz, N ;
Draenert, R ;
Stone, DR ;
Brander, C ;
Goulder, PJR ;
Rosenberg, ES ;
Altfeld, M ;
Walker, BD .
JOURNAL OF VIROLOGY, 2003, 77 (03) :2081-2092
[2]   Supraoptimal peptide major histocompatibility complex causes a decrease in Bcl-2 levels and allows tumor necrosis factor α receptor II-mediated apoptosis of cytotoxic T lymphocytes [J].
Alexander-Miller, MA ;
Derby, MA ;
Sarin, A ;
Henkart, PA ;
Berzofsky, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1391-1399
[3]   Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Sarin, A ;
Berzofsky, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :485-492
[4]   Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4102-4107
[5]   Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection [J].
Allen, TM ;
Altfeld, M ;
Yu, XG ;
O'Sullivan, KM ;
Lichterfeld, M ;
Le Gall, S ;
John, M ;
Mothe, BR ;
Lee, PK ;
Kalife, ET ;
Cohen, DE ;
Freedberg, KA ;
Strick, DA ;
Johnston, MN ;
Sette, A ;
Rosenberg, ES ;
Mallal, SA ;
Goulder, PJR ;
Brander, C ;
Walker, BD .
JOURNAL OF VIROLOGY, 2004, 78 (13) :7069-7078
[6]   Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection [J].
Altfeld, M ;
Rosenberg, ES ;
Shankarappa, R ;
Mukherjee, JS ;
Hecht, FM ;
Eldridge, RL ;
Addo, MM ;
Poon, SH ;
Phillips, MN ;
Robbins, GK ;
Sax, PE ;
Boswell, S ;
Kahn, JO ;
Brander, C ;
Goulder, PJR ;
Levy, JA ;
Mullins, JI ;
Walker, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :169-180
[7]   HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function [J].
Appay, V ;
Nixon, DF ;
Donahoe, SM ;
Gillespie, GMA ;
Dong, T ;
King, A ;
Ogg, GS ;
Spiegel, HML ;
Conlon, C ;
Spina, CA ;
Havlir, DV ;
Richman, DD ;
Waters, A ;
Easterbrook, P ;
McMichael, AJ ;
Rowland-Jones, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :63-75
[8]   HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells [J].
Betts, Michael R. ;
Nason, Martha C. ;
West, Sadie M. ;
De Rosa, Stephen C. ;
Migueles, Stephen A. ;
Abraham, Jonathan ;
Lederman, Michael M. ;
Benito, Jose M. ;
Goepfert, Paul A. ;
Connors, Mark ;
Roederer, Mario ;
Koup, Richard A. .
BLOOD, 2006, 107 (12) :4781-4789
[9]   The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration [J].
Betts, MR ;
Price, DA ;
Brenchley, JM ;
Loré, K ;
Guenaga, FJ ;
Smed-Sorensen, A ;
Ambrozak, DR ;
Migueles, SA ;
Connors, M ;
Roederer, M ;
Douek, DC ;
Koup, RA .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6407-6417
[10]   Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].
Betts, MR ;
Ambrozak, DR ;
Douek, DC ;
Bonhoeffer, S ;
Brenchley, JM ;
Casazza, JP ;
Koup, RA ;
Picker, LJ .
JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991